South Korea’s Roche Cancer Drug Polivy (Polatuzumab Vedotin) Enters Final Pricing Negotiation Stage for NHIS Coverage
South Korean health authorities have initiated pricing negotiations for Roche’s pembrolizumab (Polivy), marking the final step toward national health insurance coverage for advanced gastric cancer. The move follows regulatory approvals ... Read More